- Home
- FRSX vs HUMAW Comparison
FRSX vs HUMAW Comparison
Compare FRSX & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- HUMAW
- Stock Information
- Founded
- FRSX N/A
- HUMAW 2004
- Country
- FRSX Israel
- HUMAW United States
- Employees
- FRSX N/A
- HUMAW 220
- Industry
- FRSX Computer Software: Prepackaged Software
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- HUMAW Health Care
- Exchange
- FRSX Nasdaq
- HUMAW Nasdaq
- Market Cap
- FRSX 9.0M
- HUMAW N/A
- IPO Year
- FRSX 2017
- HUMAW N/A
- Fundamental
- Price
- FRSX $0.50
- HUMAW $0.48
- Analyst Decision
- FRSX
- HUMAW
- Analyst Count
- FRSX 0
- HUMAW 0
- Target Price
- FRSX N/A
- HUMAW N/A
- AVG Volume (30 Days)
- FRSX 480.7K
- HUMAW 14.2K
- Earning Date
- FRSX 08-08-2025
- HUMAW 03-21-2025
- Dividend Yield
- FRSX N/A
- HUMAW N/A
- EPS Growth
- FRSX N/A
- HUMAW N/A
- EPS
- FRSX N/A
- HUMAW N/A
- Revenue
- FRSX $436,000.00
- HUMAW N/A
- Revenue This Year
- FRSX N/A
- HUMAW N/A
- Revenue Next Year
- FRSX N/A
- HUMAW N/A
- P/E Ratio
- FRSX N/A
- HUMAW N/A
- Revenue Growth
- FRSX N/A
- HUMAW N/A
- 52 Week Low
- FRSX $0.45
- HUMAW $1.18
- 52 Week High
- FRSX $2.63
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- FRSX 45.18
- HUMAW N/A
- Support Level
- FRSX $0.45
- HUMAW N/A
- Resistance Level
- FRSX $0.54
- HUMAW N/A
- Average True Range (ATR)
- FRSX 0.05
- HUMAW 0.00
- MACD
- FRSX 0.01
- HUMAW 0.00
- Stochastic Oscillator
- FRSX 35.50
- HUMAW 0.00
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.